Arca
Skip to content
Tools
Tools

-pin(e)

Drugs with a three-ring core.

  • Drugs ending in -pin(e): 62
  • Approved somewhere: 36
  • With a US drug page: 21

What It Means

Stem from WHO's stem book, 2024; description by Arca
Stem
-pin(e)
Class
Drugs with a three-ring core
Most common targets
HTR2A (7), FSHR (6), CHRM1 (5), HTR2C (5), SLC6A2 (4), Sodium channel alpha subunit (4), LHCGR (3), MC2R (3)

Drugs That Carry It

Approved and clinical-stage drugs in ChEMBL whose names ending in -pin(e) or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
BenztropineApprovedCHRM1Muscarinic acetylcholine receptor M1 antagonist
Choriogonadotropin alfaApprovedLHCGRLuteinizing hormone/Choriogonadotropin receptor agonist
CorticotropinApprovedMC2RMelanocortin receptor 2 agonist
LonapegsomatropinApprovedGHRGrowth hormone receptor agonist
RifampinApprovedBacterial DNA-directed RNA polymeraseBacterial DNA-directed RNA polymerase inhibitor
SomatropinApprovedGHRGrowth hormone receptor agonist
Thyrotropin alfaApprovedTSHRThyroid stimulating hormone receptor agonist
CosyntropinPhase 3MC2RMelanocortin receptor 2 agonist
Gonadotropin, chorionicPhase 3LHCGRLuteinizing hormone/Choriogonadotropin receptor agonist
UrofollitropinPhase 3FSHRFollicle stimulating hormone receptor agonist
AtropineApprovedCHRM3, CHRM1, CHRM2Muscarinic acetylcholine receptor M3 antagonist
Corifollitropin alfaApprovedFSHRFollicle stimulating hormone receptor agonist
DibenzepinApprovedHRH1, SLC6A2Histamine H1 receptor antagonist
DothiepinApprovedSLC6A2, SLC6A4Norepinephrine transporter inhibitor
FollitropinApprovedFSHRFollicle stimulating hormone receptor agonist
Follitropin alfaApprovedFSHRFollicle stimulating hormone receptor agonist
Follitropin betaApprovedFSHRFollicle stimulating hormone receptor agonist
Follitropin deltaApprovedFSHRFollicle stimulating hormone receptor agonist
Lutropin alfaApprovedLHCGRLuteinizing hormone/Choriogonadotropin receptor agonist
MethylatropineApproved——
MethylhomatropineApproved—Unknown
PilocarpineApprovedCHRM3, CHRM1Muscarinic acetylcholine receptor M3 agonist
AlbusomatropinPhase 3——
EmoxypinePhase 3——
GenipinPhase 3——
ThyrotropinPhase 3TSHRThyroid stimulating hormone receptor agonist
BamipinePhase 2——
DeptropinePhase 2——
DroxypropinePhase 2——
EthybenztropinePhase 2——
Redalsomatropin alfaPhase 2——
Somatropin pegolPhase 2——
ZosurabalpinPhase 2——
CordycepinPhase 1——
TerpinPhase 1——
Anisotropine—CHRM3, CHRM1Muscarinic acetylcholine receptor M3 antagonist
Corticotropin zinc hydroxide—MC2RMelanocortin receptor 2 agonist
Indalpine—SLC6A4Serotonin transporter inhibitor
AmoxapineApprovedSLC6A4, SLC6A2, Dopamine receptorSerotonin transporter inhibitor
ClozapineApprovedHTR2A, DRD2Serotonin 2a (5-HT2a) receptor antagonist
MirtazapineApprovedHTR2A, HTR2C, Adrenergic receptor alpha-2Serotonin 2a (5-HT2a) receptor antagonist
NevirapineApprovedPOLHuman immunodeficiency virus type 1 reverse transcriptase inhibitor
OlanzapineApprovedHTR2A, HTR2C, D2-like dopamine receptorSerotonin 2a (5-HT2a) receptor antagonist
QuetiapineApprovedHTR2A, HTR2C, DRD2Serotonin 2a (5-HT2a) receptor antagonist
AsenapineApprovedDRD2, HTR2ADopamine D2 receptor antagonist
ClothiapineApprovedSerotonin 2 (5-HT2) receptor, DRD4, Serotonin 3 (5-HT3) receptorSerotonin 2 (5-HT2) receptor antagonist
LoxapineApprovedHTR2A, HTR2C, D2-like dopamine receptorSerotonin 2a (5-HT2a) receptor antagonist
NoscapineApproved——
EsmirtazapinePhase 3HRH1, HTR2A, HTR2C, Adrenergic receptor alpha-2Histamine H1 receptor antagonist
ZicronapinePhase 3——
TriapinePhase 2RRM1, RRM2BRibonucleotide reductase inhibitor
DoxepinApprovedSLC6A2, HRH1Norepinephrine transporter inhibitor
ZotepineApproved——
TropatepinePhase 2——
CarbamazepineApprovedSodium channel alpha subunitSodium channel alpha subunit blocker
EslicarbazepineApprovedSodium channel alpha subunitSodium channel alpha subunit blocker
Eslicarbazepine acetateApprovedSodium channel alpha subunitSodium channel alpha subunit blocker
OxcarbazepineApprovedSodium channel alpha subunitSodium channel alpha subunit blocker
PirenzepineApprovedCHRM1Muscarinic acetylcholine receptor M1 antagonist
BenzodiazepinePhase 3——
LicarbazepinePhase 3——
TelenzepinePhase 1——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.